Studies on Pharmacokinetics and Relative Bioavailability of Sinomenine Hydrochloride Sustained-Released Capsules in Dogs
Lingyan Jian
Abstract
Lingyan Jian
Abstract
OBJECTIVE To study the pharmacokinetics and bioavailability of sinomenine hydrochloride sustained-release capsules in dogs.METHODS 120 mg single oral dose of sinomenine hydrochloride sustained-release capsules and sinomenine hydrochloride sustained-release tablets were given to 6 dogs in an open randomized crossover way.sinomenine hydrochloride concentration in blood was assayed by HPLC method.RESULTS The relative bioavailability of sinomenine hydrochloride sustained-release capsules was(88.97%).The time-concentration curve of sinomenine hydrochloride sustained-release capsules was similar to that of sinomenine hydrochloride sustained-released tablets,and their AUC20-30 were(13 797.04±4 915.68) and(15 507.17±6 263.07)μg·h·L-1;ρ2max were(1 012.23±510.82) and(1 031.66±546.15)μg·L-1;t21/2 were(25.19±10.94) and(20.48±6.55)h;t2max were(8.67±1.63) and(5.7±1.51)h,respectively.The statistical analysis on above parameters showed that there was no significant difference between sinomenine hydrochloride sustained-release capsules and sinomenine hydrochlorid sustained-release tablets.CONCLUSION Two formulations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics and bioavailability of sinomenine hydrochloride sustained-release capsules in dogs.METHODS 120 mg single oral dose of sinomenine hydrochloride sustained-release capsules and sinomenine hydrochloride sustained-release tablets were given to 6 dogs in an open randomized crossover way.sinomenine hydrochloride concentration in blood was assayed by HPLC method.RESULTS The relative bioavailability of sinomenine hydrochloride sustained-release capsules was(88.97%).The time-concentration curve of sinomenine hydrochloride sustained-release capsules was similar to that of sinomenine hydrochloride sustained-released tablets,and their AUC20-30 were(13 797.04±4 915.68) and(15 507.17±6 263.07)μg·h·L-1;ρ2max were(1 012.23±510.82) and(1 031.66±546.15)μg·L-1;t21/2 were(25.19±10.94) and(20.48±6.55)h;t2max were(8.67±1.63) and(5.7±1.51)h,respectively.The statistical analysis on above parameters showed that there was no significant difference between sinomenine hydrochloride sustained-release capsules and sinomenine hydrochlorid sustained-release tablets.CONCLUSION Two formulations are bioequivalent.
Key concepts: Sinomenine, Bioavailability, Pharmacokinetics, Bioequivalence, Chemistry, Pharmacology, Chromatography, Hydrochloride